PMGC Holdings Inc. (NASDAQ:ELAB – Get Free Report) saw a significant decrease in short interest during the month of June. As of June 30th, there was short interest totaling 331,075 shares, a decrease of 44.9% from the June 15th total of 601,191 shares. Approximately 28.6% of the shares of the stock are sold short. Based on an average daily volume of 387,077 shares, the short-interest ratio is currently 0.9 days.
PMGC Stock Performance
ELAB stock opened at $1.12 on Wednesday. PMGC has a twelve month low of $1.02 and a twelve month high of $309.12. The company has a quick ratio of 1.43, a current ratio of 1.45 and a debt-to-equity ratio of 0.03. The company has a market cap of $1.30 million, a P/E ratio of -0.01 and a beta of -0.23. The business’s fifty day moving average is $1.54 and its 200-day moving average is $8.43.
PMGC (NASDAQ:ELAB – Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported ($11.22) EPS for the quarter. The company had revenue of $0.68 million during the quarter.
Analyst Upgrades and Downgrades
Get Our Latest Analysis on ELAB
About PMGC
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.
See Also
- Five stocks we like better than PMGC
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
